Skip to main content

NW London CLRN Primary Care Meeting

One of the organisations I work with is the North-West London Comprehensive Local Research Network (CLRN). The North-West CLRN is one of 25 CLRNs across England which form part of the NIHR Comprehensive Clinical Research Network (CCRN). The CCRN provides support for clinical trials and other well designed studies in all areas of disease and clinical need. A key role for the CLRN is providing infrastructure support for studies on the NIHR Portfolio. Part of this infrastructure support is in primary care. On October 7th 2009, the CLRN held a meeting with some of the local GPs and other primary care staff who collaborate with the CLRN.

One of the key points arising from the meeting was the need to get more NIHR portfolio studies active in primary care in NW London. IT issues were also discussed, particularly the need for expertise to run queries on GP Electronic Patient Record Systems such as EMIS and Vision. The need to continue reimbursement of practice expenses and also to offer additional value to GPs through involvement in research design and planning, access to training etc was also discussed, as was the high administrative workload in processing invoices for service support costs from a large number of general practices. We also discussed the need to review current levels of Clinical Study Officer (CSO) provision and to increase this if warranted by a rising number of accruals. The need for high-level GP/academic input to overcome some of the blocks that can be present in primary care research by liaising with relevant senior staff in PCTs and practices was also raised.

We will take forward these points in future CLRN meetings and with the Primary Care Research Network for Greater London (PCRN-GL).

Comments

Popular posts from this blog

What is the difference between primordial prevention and primary prevention?

Primordial prevention and primary prevention are both crucial strategies for promoting health, but they operate at different levels. Primordial prevention aims to address the root causes of health problems and improve the wider determinants of health. It focuses on preventing the emergence of risk factors in the first place by tackling the underlying social, economic, and environmental determinants of health. This involves broad, population-wide interventions such as: Policies that promote healthy food choices: Think about initiatives like taxing sugary drinks to discourage unhealthy consumption, or providing subsidies for fruits and vegetables to make them more accessible. Urban planning that prioritises well-being: This could include creating walkable neighborhoods with safe cycling routes, ensuring access to green spaces for recreation and relaxation, and designing communities that foster social connections. Social programs that address inequality: Initiatives aimed at reducing pov...

UK Covid-19 Inquiry - The Importance of a Strong Primary Healthcare System

In my witness statement for Module 10 of the UK Covid-19 Inquiry, I discuss the pandemic's impact through from the perspectives of  primary care and public health, drawing on my extensive experience as a senior academic at Imperial College London and as a practising GP and NHS Public Health Specialist.  I emphasise that the pandemic disproportionately affected people who were clinically vulnerable, the disabled, ethnic minority communities and those living in deprived areas. The pandemic highlighted how structural inequalities, multigenerational housing, and employment in high-risk frontline roles exacerbated health disparities.  My statement also critiques the weakening of public health infrastructure - particularly for the control of infectious diseases - and the lack of integrated health data systems to identify at-risk groups such as the clinically vulnerable. I also advocated for a more robust preventive healthcare model that prioritises community-based primary care ...

Protecting Young People from Meningococcal B Disease: The NHS Targeted Vaccination Programme

Meningococcal group B (MenB) infections are rare but can have devastating consequences. The decision to offer a targeted two-dose vaccination programme to Year 13 students and young people entering university or residential further education reflects concerns about recent outbreaks of meningococcal disease and the higher risk of transmission when large numbers of young adults mix closely for the first time in shared accommodation. The MenB vaccine has a well-established safety record, and evidence from the UK infant immunisation programme has shown substantial reductions in disease among vaccinated children. A targeted programme for those entering higher-risk settings is therefore a reasonable precautionary measure while further evidence is gathered on whether the recent increase in clusters represents a temporary fluctuation in disease patterns or a more sustained change in the epidemiology of MenB infection. The success of the programme will depend on achieving high uptake and ensuri...